F. A. Hayes

发表

Cytogenetic features of human neuroblastomas and cell lines.

A. Tsiatis, G. Brodeur, D. Williams, 1981, Cancer research.

Lymph node sampling in localized neuroblastoma: a Pediatric Oncology Group study.

J. Shuster, F. A. Hayes, R. Castleberry, 1999, Journal of pediatric surgery.

Surgicopathologic staging of neuroblastoma: prognostic significance of regional lymph node metastases.

A. Green, F. A. Hayes, H. O. Hustu, 1983, The Journal of pediatrics.

Localized neuroblastoma treated by surgery: a Pediatric Oncology Group Study.

J. Shuster, F. A. Hayes, S. Shochat, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.

A T Look, J J Shuster, A. Look, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients.

J. Wasson, R. Seeger, G. Brodeur, 1987, Cancer research.

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

B. Bozkurt, D. Mann, F. A. Hayes, 1999, Circulation.

Safety and Efficacy of a Soluble P 75 Tumor Necrosis Factor Receptor ( Enbrel , Etanercept ) in Patients With Advanced Heart Failure

B. Bozkurt, D. Mann, F. A. Hayes, 1999 .

Brain tumors in the very young child: Postoperative chemotherapy in combined‐modality treatment

R. Mulhern, R. Sanford, J. Jenkins, 1988, Cancer.

Clinical evaluation of sequentially scheduled cisplatin and vm26 in neuroblastoma: Response and toxicity

W. Evans, A. Green, F. A. Hayes, 1981, Cancer.

Results of Pediatric Oncology Group Protocol 8104 for Infants with Stages D and DS Neuroblastoma

J. Shuster, D. Strother, F. A. Hayes, 1995, Journal of pediatric hematology/oncology.

Long-term survival in patients with Ewing's sarcoma relapsing after completing therapy.

F. A. Hayes, H. O. Hustu, M. Kumar, 1987, Medical and pediatric oncology.

The risk of nephrectomy during local control in abdominal neuroblastoma.

R. Shamberger, F. A. Hayes, P. V. Rao, 1998, Journal of pediatric surgery.

Sequential cyclophosphamide and doxorubicin for induction of complete remission in children with disseminated neuroblastoma

A. Green, F. A. Hayes, H. O. Hustu, 1981, Cancer.

Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: the St Jude Children's Research Hospital experience, 1962 to 1988.

W. Furman, D. Parham, A. Green, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy as an alternative to laminectomy and radiation in the management of epidural tumor.

A. Green, F. A. Hayes, E. Thompson, 1984, The Journal of pediatrics.

Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation.

M. Schell, W. Meyer, A. Green, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of investigational drugs as initial therapy for childhood solid tumors.

P. Houghton, J. Houghton, W. Meyer, 1989, Haematology and blood transfusion.

Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: a Pediatric Oncology Group study.

A. Cantor, A. Green, R. Berkow, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna.

E. Douglass, W. Meyer, C. Pratt, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of ifosfamide in children with malignant solid tumors.

E. Douglass, W. Meyer, C. Pratt, 1987, Cancer treatment reports.

Malignant melanoma in children: its management and prognosis.

I. Fleming, R. Dilawari, W. Meyer, 1990, Journal of pediatric surgery.

Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma.

J. Shuster, I. Smith, M. Wharam, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ewing's sarcoma: local tumor control and patterns of failure following limited-volume radiation therapy.

D. Fairclough, W. Meyer, Y. Arai, 1991, International journal of radiation oncology, biology, physics.

t(11;22) and other chromosomal rearrangements in Ewing's sarcoma.

M. Valentine, E. Douglass, A. Green, 1986, Journal of the National Cancer Institute.

Progress against childhood cancer: the Pediatric Oncology Group experience.

J. Krischer, L. Frankel, J. Shuster, 1992, Pediatrics.

Therapy for localized Ewing's sarcoma of bone.

W. Meyer, D. Parham, F. A. Hayes, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evidence for recruitment and synchronization in leukemia and solid tumors.

S. Murphy, A. Mauer, F. A. Hayes, 1976, Cancer treatment reports.

Chest wall resection for Ewing's sarcoma of the rib: an unnecessary procedure.

J. W. Pate, I. Fleming, J. Pate, 1988, The Annals of thoracic surgery.

A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group.

D. Neuberg, J. Bennett, M. Tallman, 2004, Blood.

Clinical pharmacodynamics of continuous infusion teniposide: systemic exposure as a determinant of response in a phase I trial.

W. Evans, J. Rodman, G. Rivera, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pilot study of adjunctive GM-CSF (yeast-derived) for fluconazole- resistant oral candidiasis in HIV-1 infection

S. Swindells, F. A. Hayes, D. Kleinschmidt, 1997 .

A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490).

J. Bennett, E. Paietta, J. Rowe, 1995, Blood.

Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study.

A. Look, A. Cantor, G. Brodeur, 1997, Journal of the National Cancer Institute.

Malignant melanoma simulants arising in congenital melanocytic nevi do not show experimental evidence for a malignant phenotype.

W. Clark, M. Herlyn, F. A. Hayes, 1990, The American journal of pathology.

Immunohistochemical expression of neuron‐specific enolase and leu 7 in Ewing's sarcoma of bone

M. Schell, D. Parham, F. A. Hayes, 1989, Cancer.

Cell‐mediated immunity to varicella zoster virus in children being treated for cancer

F. A. Hayes, S. Feldman, 1978, Cancer.

Cell kinetics and chemotherapy in neuroblastoma.

A. Mauer, F. A. Hayes, 1976, Journal of the National Cancer Institute.

Serum Lactate Dehydrogenase in Childhood Neuroblastoma A Pediatric Oncology Group Recursive Partitioning Study

J. Shuster, G. Brodeur, T. Vietti, 1992, American journal of clinical oncology.

Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma.

A. Look, A. Green, F. A. Hayes, 1984, The New England journal of medicine.

Correlation of cell kinetic and clinical response to chemotherapy in disseminated neuroblastoma.

A. Green, A. Mauer, F. A. Hayes, 1977, Cancer research.

Correlation between morphologic and other prognostic markers of neuroblastoma a study of histologic grade, DNA index, N‐myc gene copy number, and lactic dehydrogenase in patients in the pediatric oncology group

A. Look, J. Shuster, J. Silverman, 1993, Cancer.

Pharmacokinetics of etoposide (VP16) in children and adolescents with refractory solid tumors.

W. Evans, P. Hutson, F. A. Hayes, 1984, Cancer research.

The response of Ewing's sarcoma to sequential cyclophosphamide and adriamycin induction therapy.

F. A. Hayes, H. O. Hustu, M. Kumar, 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Age‐linked prognostic categorization based on a new histologic grading system of neuroblastomas. A clinicopathologic study of 211 cases from the pediatric oncology group

J. Shuster, E. W. Larkin, A. Cantor, 1992, Cancer.

Phase II study of combination human recombinant GM‐CSF with intermediate‐dose cytarabine and mitoxantrone chemotherapy in patients with high‐risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): An Eastern Cooperative Oncology Group Study

W. Hiddemann, J. Liesveld, H. Lazarus, 2001, American journal of hematology.

Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor.

S. Soong, M. Ernstoff, M. Jacobs, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF) and autologous melanoma vaccine mediate tumor regression in patients with metastatic melanoma.

S. Leong, R. Allen, R. Sagebiel, 1999, Journal of immunotherapy.

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN THE TREATMENT OF NEONATES WITH NEUTROPENIA AND SEPSIS

S. Korones, Winfred C. Wang, J. Wilimas, 2000, Pediatric hematology and oncology.

The prognostic significance of autologous bone marrow transplant in advanced neuroblastoma.

J. Shuster, A. Cantor, R. Marcus, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Postoperative treatment of nonmetastatic visible residual neuroblastoma: a Pediatric Oncology Group study.

J. Shuster, A. Green, F. A. Hayes, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Infants with neuroblastoma and regional lymph node metastases have a favorable outlook after limited postoperative chemotherapy: a Pediatric Oncology Group study.

J. Shuster, N. Winick, F. A. Hayes, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ifosfamide in pediatric malignant solid tumors

E. Douglass, W. Meyer, C. Pratt, 2004, Cancer Chemotherapy and Pharmacology.

Malignant melanoma in childhood: clinical course and response to chemotherapy.

A. Green, F. A. Hayes, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hearing loss in children receiving cisplatin chemotherapy.

A. Green, G. Thibadoux, V A McHaney, 1983, The Journal of pediatrics.

GMCSF AND AUTOLOGOUS MELANOMA VACCINE MEDIATE TUMOR REGRESSION IN PATIENTS WITH METASTATIC MELANOMA

S. Leong, R. Allen, R. Sagebiel, 1995 .

Pharmacokinetic modeling of cisplatin disposition in children and adolescents with cancer

A. Tsiatis, C. Pratt, W. Evans, 1982, Cancer Chemotherapy and Pharmacology.

Chromosome 1 abnormalities: a common feature of pediatric solid tumors.

E. Douglass, A. Green, F. A. Hayes, 1985, Journal of the National Cancer Institute.

PHASE II EVALUATION OF CISPLATIN IN CHILDREN WITH NEUROBLASTOMA AND OTHER MALIGNANT SOLID TUMORS

W. Evans, N. Senzer, C. Pratt, 1980 .

Metastatic epidural tumors in children.

C. Pratt, A. Green, F. A. Hayes, 1982, Medical and pediatric oncology.

Cyclophosphamide/doxorubicin vs. cisplatin/teniposide in the treatment of children older than 12 months of age with disseminated neuroblastoma: a Pediatric Oncology Group Randomized Phase II study.

J. Shuster, A. Green, T. Vietti, 1995, Medical and pediatric oncology.

15 Adjuvant therapy of stage Iii and Iv malignant melanoma using yeast derived, Gm-csf

S. Soong, M. Ernstoff, M. Grossbard, 1997 .

Metastatic Ewing's sarcoma: remission induction and survival.

D. Parham, F. A. Hayes, L. Kun, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Systematization of primary histopathologic and fine-needle aspiration cytologic features and description of unusual histopathologic features of neuroblastic tumors: a report from the Pediatric Oncology Group.

J. Shuster, J. Silverman, E. W. Larkin, 1993, Human pathology.

Thoracic neuroblastoma: a Pediatric Oncology Group study.

J. Shuster, F. A. Hayes, R. Castleberry, 1993, Journal of pediatric surgery.

The Risk of Nephrectomy During Local Control in Abdominal Neuroblastoma

R. Shamberger, F. A. Hayes, P. V. Rao, 1999 .

Clinical trial of etoposide (VP-16) in children with recurrent malignant solid tumors

J. Krischer, F. Kung, G. Brodeur, 1988, Investigational New Drugs.

Chemotherapeutic management of epidural neuroblastoma.

D. O'connor, A. Green, F. A. Hayes, 1989, Medical and pediatric oncology.

Granulocyte-macrophage colony-stimulating factor as infection prophylaxis in high-risk oncologic surgery.

N. Petrelli, L. Blumenson, L. Vaickus, 1996, American journal of surgery.

Molecular analysis and clinical significance of N-myc amplification and chromosome 1p monosomy in human neuroblastomas.

R. Seeger, G. Brodeur, R. Griffith, 1988, Progress in clinical and biological research.

Allergic reactions to teniposide in patients with neuroblastoma and lymphoid malignancies.

A. Green, F. A. Hayes, M. Abromowitch, 1985, Cancer treatment reports.

Conventional versus modified morphologic criteria for ganglioneuroblastoma. A review of cases from the Pediatric Oncology Group.

J. Shuster, E. W. Larkin, A. Cantor, 1996, Archives of pathology & laboratory medicine.

Chest wall resection for Ewing's sarcoma of the rib: an unnecessary procedure. 1988. Updated in 1995.

J. W. Pate, I. Fleming, A. Green, 1995, The Annals of thoracic surgery.

The Subject Matter of First Philosophy

F. A. Hayes, Raul Corazzon, 2018 .

Growth regulations of human malignant cells.

S. Murphy, A. Mauer, F. A. Hayes, 1980, Results and problems in cell differentiation.

Primary Ewing sarcoma: follow-up with Ga-67 scintigraphy.

H. Magill, F. A. Hayes, E. Thompson, 1990, Radiology.

International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma.

C. R. Pinkerton, B. Bernardi, A. Barrett, 1988, Progress in clinical and biological research.

W. Hiddemann, J. Liesveld, G. Dewald, 2001, American journal of hematology.

Tetany: a complication of cis-dichlorodiammineplatinum(II) therapy.

N. Senzer, C. Pratt, A. Green, 1979, Cancer treatment reports.